|
|
|
|
MODELING TO OPTIMIZE ISLATRAVIR QW DOSE IN HIV VIROLOGICALLY SUPRESSED PWH
|
|
|
CROI 2023 Feb 20-23
Ryan C Vargo1, Seth Robey1, Xiaowei Zang1, Lihong Du1, Bhargava Kandala1, Jessica Roberts2, Stephanie Klopfer1, Kathleen Squires1 1Merck & Co., Inc., Rahway NJ, USA; 2Simulation Plus, Cognigen Division, Buffalo, New York, USA
|
|
|
|
|
|
|